TOKYO, Jun 25 (Pulse News Wire) – Medikit CO.,LTD. (7749.T) resolved to distribute restricted shares to executives on June 25, 2026.
A total of 12,700 ordinary shares will be distributed at a price of ¥2,787 per share, amounting to a total value of ¥35.4 million. The recipients include three directors, four executive officers who do not concurrently hold director positions, and six executive officers of subsidiaries, each receiving 2,000 shares. This distribution follows the introduction of a restricted stock compensation program aimed at incentivizing long-term performance and aligning interests with shareholders.
Under this program, approved by the board in May 13, 2022, and ratified by shareholders on June 29, 2022, eligible executives receive restricted shares based on their contributions and the company's performance. The shares will be subject to restrictions until July 24, 2026, or upon retirement due to normal reasons such as reaching mandatory retirement age. In addition, the company will acquire unrestricted shares free of charge if an executive violates laws during the restriction period or fails to meet the conditions set forth in the agreement.
The shares will also be managed through a dedicated account at Nomura Securities to ensure compliance with the restrictions.
🟡 Confidence: Standard AI-translated content.